University of Wisconsin–Madison

Updates in Geriatrics

Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.

Older people living with multiple chronic diseases often have a high risk of adverse health events which can be modified by medicines. Despite the great potential benefit they can derive from medicines, the elderly are at high risk of experiencing medicine-related harm. Using more drugs than is clinically indicated can increase this risk. This series of lectures will look at tools for desprescribing as well as many other issues facing the aging. The goal of the 2021 Fall Distance Learning Experience is to provide pharmacists with an update on advances and updates in the treatment of conditions affecting the older adult, and to enable pharmacists to assume an active role in the management of these conditions. 

Registration Information

Register

Refund Policy

Course date:Oct 1, 2021 - Oct 1, 2024
Location:
Course fee:

$200

$150 UW Clinical Instructors & Retired Pharmacists:

Clinical instructors for selected UW School of Pharmacy experiential programs (e.g., 740, 741 & 760), who provide at least six lecture/discussion hours for SOP courses and retired pharmacists.

Course Objectives

As a result of participating in this program, learners should be able to:

  • Describe strategies for deprescribing medications that are no longer indicated, appropriate or aligned with the goals of care of the older adult.
  • Identify dementia-related behavioral symptoms
  • Describe pharmacotherapy treatment options for dementia
  • Identify management strategies for older adults with COPD
  • Learn how to educate older patients on the process of Teleheath/DM
  • Describe the effect of Herbals and Supplements as they apply to the older populations over all medication strategy.
  • Explain the special considerations for using DOACS with elderly patients.
  • Discuss strategies for care teams to align palliative options with quality of life for patients.

Course Outline

 

Lecture 1

COPD Management with the Elderly
Presenter: Ed Portillo, PharmD, Assistant Professor (CHS), UW-Madison, School of Pharmacy

Lecture 2

Desprescribing Overview
Presenter: Mara Kieser, MS, RPh, BCGP, Professor, (CHS) and Assistant Dean, UW-Madison, School of Pharmacy

Lecture 3

Tools for Deprescribing
Presenter: Lauren Welch, PharmD, BCGP, Clinical Geriatric Pharmacy Specialist, William S Middleton VA Hospital

Lecture 4

Roles of the Pharmacist in Palliative Care and Management of Symptoms at the End of Life
Presenter: Cory Sarver, PharmD, BCPS, Clinical Pharmacist, UW Hospital and Clinics/Agrace Hospice

Lecture 5

DOACs in Older Adults
Presenter: Allison Reindeau, PharmD, BCACP, Clinical Pharmacist, William S Middleton VA Hospital

Lecture 6

Herbals and Supplements in the Older Adult
Presenter: Trisha Seys Ranola, PharmD, CDE, CGP, Clinical Assistant Professor (CHS), Assistant Director-Office of Global Health, UW-Madison

Lecture 7

Behavioral and Psychological Symptoms of Dementia (BPSD)

Presenter: Tracy Head, PharmD, BCGP, Clinical Staff Pharmacist, Oakwood Village Retirement Communities

Lecture 8

Telehealth and Diabetes Management in the Geriatric Population

Presenter: Marisa Goninen, PharmD, BCACP, Manager of Pharmacy, Population Health, Advocate Aurora Health 

Instructors

Policy on Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

Marisa Goninen, PharmD, BCACP, Manager of Pharmacy, Population Health, Advocate Aurora Health
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes

Tracy Head, PharmD, BCGP, Clinical Staff Pharmacist, Oakwood Village Retirement Communities, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes

Mara Kieser, MS, RPh, BCGP, Professor, (CHS) and Assistant Dean, UW-Madison, School of Pharmacy, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Ed Portillo, PharmD, Assistant Professor (CHS), UW-Madison, School of Pharmacy, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Allison Reindeau, PharmD, BCACP, Clinical Pharmacist, William S Middleton VA Hospital, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Cory Sarver, PharmD, BCPS, Clinical Pharmacist, UW Hospital and Clinics/Agrace Hospice, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Trisha Seys Ranola, PharmD, CDE, CGP, Clinical Assistant Professor (CHS), Assistant Director-Office of Global Health, UW-Madison, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Lauren Welch, PharmD, BCGP, Clinical Geriatric Pharmacy Specialist, William S Middleton VA Hospital, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No

Planning Committee

Eric Buxton, PhD, Associate Professor, Chair, Division of Pharmacy Professional Development, School of Pharmacy, UW-Madison, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose

Mara Kieser, MS, RPh, Professor, Pharmacy Practice Division, School of Pharmacy, UW-Madison, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose

Beth Martin, PharmD, PhD, Professor, Chair, Pharmacy Practice Division, School of Pharmacy, UW-Madison, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose

Lauren Welch, PharmD, BCPS, Clinical Geriatric Pharmacy Specialist, William S Middleton VA Hospital, Madison, WI
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose

 

CE Credit

ICEP LogoAccreditation Statements

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 12 hours (1.2 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. There will be no partial credit awarded for partial completion.

Enduring (home study): JA0000358-0000-21-112-H04-P (1.2 CEUs)
Release Date: 10/1/2021 Expiration Date: 10/1/2024

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.2 CEUs or 12 hours.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu